Home › Funds › Foresite Capital Management V, LLC › PHVS

Foresite Capital Management V, LLC position in PHVS

PHARVARIS N V · Health Care

Foresite Capital Management V, LLC reported holding 664,142 shares of PHVS (PHARVARIS N V) in its Q2 2026 13F filing — a position valued at US$23.0M, representing 6.34% of its reported portfolio and ranking #5 among its reported holdings. Foresite Capital Management V, LLC has disclosed PHVS holdings in 3 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)664.14K sh
Reported value held$22.97M
Portfolio Weight6.34%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Foresite Capital Management V, LLC's PHVS position evolved

Foresite Capital Management V, LLC first disclosed a stake in PHVS in Q3 2023 at 33,142 shares (US$692K). The position peaked in Q2 2026 at 664,142 shares, worth US$23.0M. Across 3 filings, Foresite Capital Management V, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 664,142 shares valued at US$23.0M — an increase of 470,017 shares quarter over quarter.. Notable position changes include a 242% increase in Q2 2026 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 33.14K $691.67K New
Q1 2026 194.12K $5.48M New
Q2 2026 664.14K $22.97M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PHVS and 13F data

PHVS (PHARVARIS N V) is a Health Care company. 49 other funds we track also report a position in PHVS — the largest reported positions include GENERAL ATLANTIC, L.P. (US$226.5M), Foresite Capital Management IV, LLC (US$165.2M), venBio Partners LLC (US$160.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PHVS

All PHVS fund holders →

FAQ

How long has Foresite Capital Management V, LLC held PHVS?

Foresite Capital Management V, LLC has disclosed PHVS holdings in 3 of the last 12 reported quarters, going back to Q3 2023.

What is Foresite Capital Management V, LLC's current position in PHVS?

As of Q2 2026, Foresite Capital Management V, LLC holds 664.14K shares of PHVS (PHARVARIS N V), valued at $22.97M, representing 6.34% of its reported portfolio and ranking #5.

Has Foresite Capital Management V, LLC been buying or selling PHVS?

In the latest 13F filing (Q2 2026), Foresite Capital Management V, LLC increased its position in PHVS. The position peaked in Q2 2026 at 664.14K shares.

Which other funds hold PHVS?

Other major institutional holders of PHVS include GENERAL ATLANTIC, L.P., Foresite Capital Management IV, LLC, venBio Partners LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.